CADTH Reimbursement Recommendation - Belumosudil (Rezurock) - Indication: For the treatment of adult and pediatric patients 12 years and older

If your institution is a member, please log into Policy Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Accessing this content requires a membership

If your institution is a member, please log into Policy Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.